Completed PHASE2 INTERVENTIONAL 1-arm NCT02104440

Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro

Sponsor: Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán

Conditions Cytopenia

Interventions Sequential infusion of allogeneic mesenchymal stem cells expanded in vitro

Updated 6 times since 2017 Last updated: Mar 29, 2017 Started: Oct 31, 2013 Primary completion: Mar 31, 2017 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cytopenia and is currently completed. Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Apr 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — Apr 2017 [monthly]

Unknown Status PHASE2

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán
Hospitales Universitarios Virgen del Rocío
Red de Terapia Celular
Spanish National Health System
University of Navarrra Hospital (Clinica Universitaria)

Data source: Red de Terapia Celular

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salamanca, Spain